Covalently PEGylated Carbon Nanotubes with Stealth Character In Vivo
Source abstract
Abstract
Stealth nanotubes: The stealth character of covalently PEGylated single-walled nanotubes (SWNTs, indicated by arrows in image) in vivo is studied. The nanotubes exhibit much longer blood-circulation half-life in vivo than the previous record for nanotubes and also a low hepatic uptake, vital to uses in drug-delivery systems. The benefits are reflected in the observed high tumor uptake of PEGylated SWNTs.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Carbon Nanotubes in Composites
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. 10.1039/b314481j10.1039/b314481j ↗
2. 10.1109/TNB.2005.85047810.1109/TNB.2005.850478 ↗
3. 10.1016/j.cbpa.2005.10.00510.1016/j.cbpa.2005.10.005 ↗
4. 10.1166/jnn.2004.14610.1166/jnn.2004.146 ↗
5. 10.1016/j.carbon.2007.03.03510.1016/j.carbon.2007.03.035 ↗
6. 10.1021/jp070712c10.1021/jp070712c ↗
7. 10.1073/pnas.060926510310.1073/pnas.0609265103 ↗
8. 10.1038/nnano.2006.17010.1038/nnano.2006.170 ↗
9. 10.1073/pnas.050900910310.1073/pnas.0509009103 ↗
10. 10.1021/ja050342a10.1021/ja050342a ↗
11. 10.1080/0895837049043959710.1080/08958370490439597 ↗
12. 10.1002/(SICI)1096-9888(199603)31:3<225::AID-JMS319>3.0.CO;2-L10.1002/(SICI)1096-9888(199603)31:3<225::AID-JMS319>3.0.CO;2-L ↗
13. Platzner I. T. · 1997
14. Caprioli R. M. · 2005 · 341
15. 10.1016/j.toxlet.2005.08.01110.1016/j.toxlet.2005.08.011 ↗
16. 10.1016/j.ijpharm.2005.10.01010.1016/j.ijpharm.2005.10.010 ↗
17. 10.1002/jps.260084042010.1002/jps.2600840420 ↗
18. 10.1021/jp031248o10.1021/jp031248o ↗
19. 10.1002/jps.260072100310.1002/jps.2600721003 ↗
20. 10.1016/j.ejps.2005.08.00210.1016/j.ejps.2005.08.002 ↗
21. 10.1016/S0168-3659(01)00218-810.1016/S0168-3659(01)00218-8 ↗
22. 10.1016/S0168-3659(99)00248-510.1016/S0168-3659(99)00248-5 ↗
23. 10.1002/anie.20050211310.1002/anie.200502113 ↗
24. 10.1016/j.addr.2006.09.01510.1016/j.addr.2006.09.015 ↗
25. 10.1021/nl061160x10.1021/nl061160x ↗
26. 10.1021/nl034083410.1021/nl0340834 ↗
27. 10.1021/la036217z10.1021/la036217z ↗
28. 10.1021/jp072346310.1021/jp0723463 ↗
29. The thermal method[20a 23]in the functionalization of SWNTs with amino molecules presumably forms zwitterionic bonds between the amino groups and the nanotube‐bound carboxylic acids (due to the oxidation of carbon defects) [22]though the actual mechanism and chemical structures are likely more complex and also dependent on the use of different amino molecules. For PEG1500N specifically the thermal method yields functionalized SWNTs that are essentially the same as those from the acylation‐amidation method[20]except for being experimentally more effective and stable (reproducible) [21]thus selected in this study.
30. 10.1021/jp002596i10.1021/jp002596i ↗
31. 10.1016/S0009-2614(01)01035-110.1016/S0009-2614(01)01035-1 ↗
32. 10.1002/jps.2068310.1002/jps.20683 ↗